GRP1 is a member of a family of proteins that contain a coiled-coil region, a Sec7 homology domain with guanosine nucleotide exchange activity for the ARF GTP binding proteins, and a PH domain at the COOH-terminus. The PH domain of GRP1 binds phosphatidylinositol (3,4,5) trisphosphate and mediates translocation of GRP1 to the plasma membrane upon agonist stimulation of PI 3-kinase activity. Using a 32 P-labeled GRP1 probe to screen a mouse brain cDNA expression library, we isolated a cDNA clone encoding a GRP1
INTRODUCTION
Numerous agonists acutely stimulate PI-3 kinase activities which generate the secondary messengers phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P 2 ), and phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P 3 ) , Czech, 2000 , Rameh and Cantley, 1999 , Vanhaesebroeck and Waterfield, 1999 , Toker, 2000 , Vanhaesebroeck and Alessi, 2000 .
The polyphosphoinositides control such diverse phenomena as membrane trafficking, chemotaxis, membrane ruffling, cell adhesion, prevention of apoptosis, differentiation and oncogenic transformation of cells. To define downstream targets for these messengers, we isolated GRP1 by screening for clones that code for proteins that bind labeled 3 phosphoinositides with high affinity (Klarlund et al., 1997) . GRP1 contains a C-terminal PH domain that binds PtdIns(3,4,5)P 3 with high specificity and a central sec7 guanosine nucleotide exchange domain (Klarlund et al., 1998) . A likely function of the molecule is to couple the production of PtdIns(3,4,5)P 3 in the cell membrane to activation of the small GTP binding protein ARF6 (Frank et al., 1998 , Langille et al., 1999 , Venkateswarlu and Cullen, 2000 . GRP1
is part of a large family of proteins that include ARNO and cytohesin-1, which have been implicated in regulation of integrin function (Geiger et al., 2000) , synaptic vesicle release (Ashery et al., 1999) , exocytosis in chromaffin cells (Caumont et al., 2000) , and desensitization of the lutenizing hormone receptor (Mukherjee et al., 2000) .
The GRP1 family of proteins is recruited to the plasma membrane in many systems upon agonist stimulation by a mechanism that requires the presence of a functional PH domain and that is sensitive to inhibitors of PI-3 kinase (Venkateswarlu et al., 1998 , Langille et al., 1999 , Venkateswarlu et al., 1999 . The initial interpretation was that recruitment occurs by direct binding to acutely generated PtdIns(3,4,5)P 3 . However, the mechanism of recruitment may have an additional component: ARF6 activates PI(4)P-5 kinase resulting in high local concentrations of PtdIns(4,5)P 2 , which is now recognized as a signaling molecule in its own right (Czech, 2000 , Hinchliffe, 2000 . We have found that the double or triple glycine motif in the loop connecting 4 poorly whereas variants that contain three glycines bind PtdIns(4,5)P 2 almost as well as PtdIns(3,4,5)P 3 . The triple glycine variants could therefore act as downstream mediators of both PtdIns(4,5)P 2 and PtdIns(3,4,5)P 3 , whereas the double glycine variants would be expected only to convey signals from PtdIns(3,4,5)P 3 . Remarkably, it was reported that GRP1, ARNO and cytohesin-1 all exist as variants that contain either two or three glycine residues in the same individual (Ogasawara et al., 2000) , suggesting a diversity of signaling functions of these molecules.
Might the GRP1 family proteins have partner proteins that further modulate their localization and functions? An N-terminal sequence of approximately 50 amino acids in the GRP1-like proteins have a high probability of forming coiled coil structures according to the coils algorithm ( Lupas, 1996) . Coiled coil domains typically function as sites of protein/protein interactions leading to formation of homo-or heterooligomers. We report here the identification of a GRP1 binding protein, GRSP1, that interacts with the coil-coil domain of GRP1. It is associated with endogenous GRP1 in intact cells, and translocates with GRP1 to the plasma membrane of cells stimulated with insulin. 
EXPERIMENTAL PROCEDURES
Immunoprecipitation. -For analysis of possible GRP1/GRP1 interaction, COS-1 cells were seeded in 6 cm tissue culture dishes, and transfected the following day with the indicated amounts of GRP1 constructs containing either a HA or myc tag in the PCMV5 vector using LipofectAMINE Plus (GIBCO-BRL) (Langille et al., 1998) . 48 hours later, the cells were scraped in 0.5 ml lysis buffer (20 mM HEPES, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM benzamidine, 5 µg/ml leupeptin, 5 µg/ml aprotinin, 25 mM sodium fluoride, 1 mM sodium orthovanadate, 1 % NP40, 1 mM dithioerythritol) and clarified by centrifugation at 20.000 g for 5 minutes. Protein concentration was determined using the BCA reagent (Pierce) and adjusted to 1 mg/ml. 7.5 µl of a polyclonal antibody directed to the HA epitope produced in this laboratory, or 100 µl of tissue culture supernatant of the anti-myc hybridoma MYC 1-9E10.2 (American Type Culture Collection) was added to 100 µl of extract. After incubation for 4 hours or overnight, 25 µl of Protein A Sepharose beads (Sigma) or 25 µl immobilized anti-mouse IgG (Cappel) was added, and incubated for 2 hours on an end-over end mixer. After three rapid washes with 1 ml lysis buffer, the protein bound to the beads were analyzed by Western blotting using the same antisera.
For analysis of the interaction of GRSP1 and GRP1 in COS-1 cells, 2 µg of a pCMV5 construct coding for the 115 kDa lung form of GRSP1 was transfected with 2 µg of pCMV5 encoding GRP1 and precipitation was performed from extracts containing 0.5 mg protein with 15 µl antiserum directed against GRP1 (Langille et al., 1998) , or 15 µl antiserum produced by injecting rabbits with 5 gluthahione-S-transferase fusion proteins with GRSP1 spanning amino acid 57 to 981. The sera were blocked by incubation with a mixture of the same fusion proteins.
Western blotting was performed using affinity purified antibodies of the sera (Langille et al., 1998) . To determine the presence of GRSP1 in intact tissues, various organs were frozen in liquid nitrogen, and homogenized in lysis buffer with 1 % SDS substituted for the NP40 using a
Polytron
R homogenizer. To analyze the presence of GRP1/GRSP1 complexes in intact tissues, lungs from BALB/c mice were homogenized in lysis buffer, clarified by centrifugation and aliquots corresponding to 2 mg of protein was imunoprecipitated as above using 7.5 µg immunopurified GRP1 or GRSP1 antibody.
Cloning of GRSP1-GST-GRP1 was engineered to contain an A kinase site by addition of the coding sequence for the amino acids RASVV at the C terminus, and the construct was expressed and purified by standard procedures (Pharmacia A mouse brain expression library from C57 black mice (Stratagene) was plated, protein expression induced and transferred to nitrocellulose filters as described (Klarlund and Czech, 2000) . The filters were washed 3-4 times in wash buffer (20 mM HEPES, pH 7.4, 100 mM NaCl, 1 mM MgCl 2 , and 0.5 mM dithioerythritol) until all visible cell debris was removed. The filters were blocked for 1-2 hours with 5% fat-free dry milk dissolved in wash buffer. They were then washed, and incubated with the probe overnight under constant agitation in binding buffer at 4 o C (wash buffer supplemented with 0.5 mM ATP, 10 mM sodium phosphate, 1 mM sodium vanadate, 25 mM NaF, 1 mM benzamidine, 0.5 µg/ml leupeptin, 0.5 µg/ml aprotinin, pH 7.4).
The filters were washed for 20-30 minutes with wash buffer, and subjected to autoradiography.
The 5 extensions were isolated from the same brain library or from a lung library (Stratagene) by standard procedures.
Preparation of GST fusion proteins and competition assay-
The GST fusion products of GRP1 fragments of GRP1 were produced as previously described (Klarlund et al, 1997) . To make GST-FERM, EcoRI, HindIII, and SalI restriction sites were introduced with oligonucleotides (AATTCCATGTGCCAGGTTCACCTGCTGGATGACAGAAGACTGGAGC TGCTGGTTCAGCCCAAGCTTATATCCTTATGATGTTCCTGATTATGCATGAG and GGT ACACGGTCCAAGTGGACGACCTACTGTCTTCTGACCTCGACGACCAAGTCGGGTTCG AATATAGGAATACTACAAGGACTAATACGTACTCAGCT), which were inserted into EcoRI and SalI sites of pBlueScript. The HindIII fragment (nucleotides 367 -1248) of pBlueScript-GRSP1 was then inserted into HindIII site inside the oligonucleotide sequence.
EcoRI/ SalI fragment of pBlueScript-FERM was subcloned into the pGEX-5X-3 vector. For GST-CC1, two primers (CAGTGGATCCAAATGAGCAATGGCAGCCTGATATCC and GAGGAATTCCTCGCCTCCTGACCTGAGG) were used to amplify the first coiled coil fragment which was subcloned into the BamHI and EcoRI sites of pGEX-5X-3. For GST-CC2, the PCR product with two primers (GCTCTAGATCTCTATGTATCCACTGAACATAGGC
GAG and GATATCGAATTCCATTGGGGTCGTCATAGGTGG) was inserted into BamHI and
EcoRI sites of pGEX-5X-3. For GST-INT, the fragment was amplified by PCR with the primers (GCTGGATCCAGAAGGCTGCCGTTGTC and GACAGATCTCGAGTCAGGACGGGCGA GTGG) and inserted into BamH1 and XhoI sites of pGEX-5X-3. For GST-ST1, two primers (GCGCAGAATTCGAGATCTAAGTCTCTCGGAATTGAGCGA and GACCGCGTGCCACA TAACTGAGAATTCCTCGAGCGATC) were used for PCR. The fragment was subcloned into
BamHI and EcoRI sites of pGEX-2TK. GST-ST2 was made by PCR with the primers (GCGCAGAATTCGGGATCCGACCGCGTGCCACATAACC and GAAGGCATCAAAGGCT GAGAATTCCTCGAGCGATC) and subcloning into BamHI and XhoI sites of pGEX-5X-3.
The GST-fused full length GRSP1 protein was insoluble and not used in this study. For the competition assay 0.25 µM of the fusion proteins were incubated with the labeled GRP1 probe and the processed filters as described (Klarlund et al, 1997) . The experiments were performed at least twice.
Immunofluorescence Microscopy-10 5 CHO-T cells were seeded on coverslips in 12 well tissue culture dishes in RPMI medium supplemented with 10 % fetal calf serum and antibiotics.
The following day, the cells were transfected with 5 ng pCMV5 encoding a construct of GRP1 containing a myc tag at the C-terminus, 100 ng pCMV5 encoding the lung form of GRSP1 containing a HA tag at the C-terminus, and 400 ng of empty pCMV5 vector using 
RESULTS AND DISCUSSION
To test whether homo-oligomers of GRP1 might be present in intact cells, COS-1 cell were transfected with various ratios of the PCMV5 expression vector coding for GRP1 with an HA or a myc tag attached to the C-terminal parts of the molecule. Cells were lysed, and immunoprecipitated with either anti-HA or anti-myc antibodies. The conditions were optimized such that almost complete precipitation of the molecules was achieved. As is seen in Figure 1 , HA-tagged-GRP1 was readily observed by Western blotting in anti-HA precipitates, and mycGRP1 was clearly seen in anti-myc precipitates. Importantly, no mycGRP1 was evident in anti-HA precipitates, and no HA GRP1 was evident in anti-myc precipitates. Similar experiments were performed with HA labeled GRP1 and myc labeled cytohesin-1 and again no coimmunoprecipitation was evident (data not shown). These experiments do not support the existence of a tight interaction between GRP1 molecules or between GRP1 and cytohesin-1 molecules in intact cells, although small amounts of such oligomers might escape detection.
ARNO expressed in E. Coli was reported to elute with an apparent molecular weight of 90 kDa in gel filtration columns (Chardin et al., 1996) . It is possible that dimerization is a unique property of ARNO. Alternatively, dimers could form as a consequence of the very high expression levels attained in bacteria. Also, divergence from a globular shape can lead to overestimation of molecular weights of proteins by gel filtration.
We next addressed the question whether GRP1 might interact with other cellular proteins.
A cAMP dependent protein kinase site was created at the C-terminus of gluthathione-Stransferase (GST) fusions of the GRP1 molecule, and it was phosphorylated by incubation with [γ-32 P]ATP and the kinase. The probe was used to screen a brain expression library, and a clone containing an open reading frame coding for a protein of 112 kDa was isolated. The clone was named GRP1 Signaling Partner 1 (GRSP1). A protein identical to the lung form of GRSP1 except for two conserved and two non conserved amino acid differences has been deposited in GenBank (gi11022657). Since this was isolated from a different mouse strain, the differences may represent allelic variation. Also, similar sequences have been described from human brain construct (Grifman et al., 1998 ). An antibody was prepared against GRSP1, various tissues examined for the expression of GRSP1 by Western-blotting, and significant amounts of immunoreactivity were found in brain and lung ( Fig. 2A) . Interestingly these tissues also express high amounts of GRP1 as detected by Western-blotting (Klarlund and Czech, unpublished data) .
A protein with an apparent molecular weight of 125 kDa was specifically recognized by the anti-GRSP1 antibody in lung. An extension of the cDNA was isolated from a lung library that had an in-frame stop codon that would yield a protein with a predicted molecular weight of 115kDa.
RT-PCR analysis of RNA isolated from lung confirmed the presence of the extension in lung tissue (data not shown). The predicted molecular weight is slightly smaller than predicted by the Western blot, but we note that the protein migrated with an apparent molecular weight of approximately 125 kDa when expressed in COS-1 cells (Fig. 5A ). An extended cDNA clone from brain was also isolated. The sequence was similar up to the initiating methionine, but diverged sharply thereafter, indicating the presence of an alternatively spliced variant of GRSP1 in brain. These results are consistent with the detection of a 225kDa protein that reacts with anti-GRSP1 antibody in brain ( Fig. 2A ), but we cannot exclude the possibility that this species is a cross-reacting protein rather than a splice variant.
Examination of the GRSP1 cDNA clone revealed the presence of several identifiable protein/protein interaction motifs. A FERM domain was identified at the amino terminus. This domain was originally found in the erythrocyte band 4.1 protein, ezrin, radixin and merlin, and has since been discovered in several classes of tyrosine phosphatases, JAK and the focal adhesion kinase and is involved in protein-protein interactions (Girault et al., 1998 , Bretcher, 1999 , Pearson et al., 2000 . In addition, two regions have a high probability of forming coiled coil structures, according to the coils program (Lupas, 1996) .
To determine the site of interaction of GRP1 with GRSP1, we designed a GRP1 domain competition assay. The isolated λ-cDNA-clone coding for GRSP1 (corresponding to amino acids 57-981) was plated on bacterial cell lawns, blotted to nitrocellulose filters and incubated with the 32 P-labeled GST-GRP1 protein. A series of unlabeled GST fusion proteins containing various regions of GRP1 was included in the incubations (Fig. 3A) . As expected, inclusion of the entire GRP1 molecule resulted in marked reduction of the signal compared to that seen without competitor (Fig. 3B) . Also, inclusion of a GST fusion with just the amino terminal 56 residues completely abolished binding of labeled GST-GRP1, whereas constructs containing the sec7 domain or the PH domain had no effect on the signal. We conclude that the site of interaction of GRP1 with GRSP1 is at the N-terminal coiled coil domain of GRP1. By the same approach, 6
GST fusion proteins of GRSP1 spanning amino acids 7-981 were analyzed (Fig. 4A) , and the region of interaction was identified to be included in a GST fusion protein with amino acids 350-443 of GRSP1, which contains the coiled coil domain 1 (Fig. 4B ).
To examine whether GRP1 and GRSP1 are able to interact in intact cells, the proteins were co-expressed in COS-1 cells. Immunoprecipitation was performed either with the GRP1 antibody or the anti-GRSP1 antibody, and the precipitates analyzed by Western blotting. As is seen in Figure 5A , a clear signal from GRSP1 was seen in anti-GRP1 immunoprecipitates, and likewise GRP1 was present in GRSP1 precipitates. No co-precipitation was observed when COS-1 cells were transfected separately and the extracts subsequently mixed, indicating that the association is not a post-lysis event. The observation that lung tissue contains substantial amounts of both GRSP1 and GRP1 allowed us to test whether complexes of endogenous GRP1/GRSP1 occur in intact tissue. The tissue was homogenized, and immunoprecipitates analyzed for presence of GRP1 and GRSP1. As is seen in Figure 5B , cross-precipitation by the antibodies was clearly evident. The conditions were chosen such that a majority of the GRP1 and GRSP1 present was precipitated. Interestingly, whereas the GRSP1 antibody precipitated only a small amount of the GRP1 present in the total lysate, anti-GRP1 antibody precipitated GRSP1 almost quantitatively. This indicates that most of the GRSP1 is complexed with GRP1 in lung tissue, whereas the majority of GRP1 exists either free or complexed to other proteins.
To determine the subcellular localization of GRSP1, a construct containing a C-terminal HA tag was prepared and transfected into Chinese hamster ovary cells expressing the insulin receptor (CHO-T cells). In cells expressing low amounts of the construct, the protein was localized diffusely in the cytoplasm, and when co-expressed with myc-tagged GRP1 the two proteins appeared to have a similar disperse localization (Fig. 6A) . In cells expressing high amounts of GRSP1, it was primarily localized in intracellular globular structures, but since artefactual localization is common under such conditions, the significance of this observation is unclear. Ruffles are readily induced in CHO-T cell by stimulation with insulin, and we have previously reported that GRP1 translocates to the plasma membrane ruffles in these cells (Langille et al., 1998) . Importantly, co-translocation and co-localization of GRP1 and GRSP1 is clearly evident in ruffles of cells expressing both proteins (Fig. 6A) . In further experiments, it was found as expected that both GRSP1 and GRP1 co-localized with F-actin in membrane ruffles of insulin-treated CHO-T cells (Fig. 6B) . Control experiments demonstrated that the green fluorescent protein, which is constitutively cytoplasmic, is not translocated to ruffles when co-expressed with GRP1.
Translocation of GRP1 and its isoforms has mainly been studied in systems that overexpress the GRP1 family of proteins. By saturating binding sites for endogenous GRP1 binding proteins such experimental systems presumably overemphasize analysis of the properties of free GRP1 molecules. A prevalent model is that free GRP1 molecules translocate simply as a result of binding to phosphoinositides generated by agonists in the plasma membrane. However, the observation that 50 % of ARNO is found in particulate fraction in several cell lines suggest that a significant fraction of the GRP1 family of proteins do not exist as free molecules (Frank et al., 1998) . Indeed, localization may be determined by properties of binding partners: The complete cytohesin-1 molecule translocates to the plasma membrane in agonist-stimulated CHO-T cells, but the isolated PH domain does not (Klarlund et al., 2000) . Thus, there appears to be an interaction between either the sec7 or the coiled coil domain with some cellular component that mediates the movement. Munc13-1 is a presynaptic protein that is translocated to diacylglycerolcontaining membranes in presynaptic active zones. Since it has been demonstrated to bind cytohesin-1, it may possibly function as an adaptor to target cytohesin-1 to diacylglycerol in membranes rather than to phosphoinositides (Neeb et al., 1999 , Brose et al., 2000 . GRASP is a very recently described protein that appears to anchor GRP1 to the plasma membrane in a constitutive manner (Nevrivy et al, 2000) . Since GRASP appears to be constitutively present at the plasma membrane, it remains an interesting issue whether its GRP1 binding activity is regulated in any way to mediate the observed agonist-induced translocation of GRP1.
The primary role of the GRP1 family of molecules may be to serve as parts of larger signaling complexes. It is noteworthy that the GRP1 family of molecules probably has 10-15 members. The greatest sequence heterogeneity is in the coiled coil domain, which serves to 13 anchor these proteins to binding partners (Neeb et al., 1999, Nevrivy et al., 2000, and this communication) suggesting that the individual members may be part of distinct complexes. This, together with the observation that at least some of the GRP1-like proteins exist in forms with great differences in phosphoinositide binding specificities (Klarlund et al, 2000) suggests that they participate in a wide range of biological functions. A primary objective of future studies is to determine the function of GRSP1 signaling in association with GRP1. 
